Bristol Myers Squibb to Participate in Wolfe Research’s 2nd Annual Virtual Healthcare Conference

- November 11th, 2020

Bristol Myers Squibb today announced that the company will take part in a fireside chat at Wolfe Research’s 2 nd Annual Virtual Healthcare Conference, which will be webcast on Wednesday, November 18, 2020. Giovanni Caforio M.D., Board Chair and Chief Executive Officer will answer questions about the company at 9:15 a.m. EST. Investors and the general public are invited to listen to a live webcast of the session at …

Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Wolfe Research’s 2 nd Annual Virtual Healthcare Conference, which will be webcast on Wednesday, November 18, 2020. Giovanni Caforio , M.D., Board Chair and Chief Executive Officer will answer questions about the company at 9:15 a.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com . An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .

corporatefinancial-news

Bristol Myers Squibb
Media:
media@bms.com

Investor Relations:
Tim Power
609-252-7509
timothy.power@bms.com
Nina Goworek
908-673-9711
nina.goworek@bms.com

News Provided by Business Wire via QuoteMedia

  Life Science and Healthcare Investing in 2020 report cover

Life Science and Healthcare Investing in 2020

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2020 life science outlook report!
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply